| 000 | 01446 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514014601.0 | ||
| 264 | 0 | _c20011207 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diabetes.50.11.2598 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, C | |
| 245 | 0 | 0 |
_aRosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway. _h[electronic resource] |
| 260 |
_bDiabetes _cNov 2001 |
||
| 300 |
_a2598-602 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGlucose _xpharmacology |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xphysiology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aRosiglitazone |
| 650 | 0 | 4 |
_aThiazoles _xpharmacology |
| 650 | 0 | 4 | _aThiazolidinediones |
| 700 | 1 | _aChang, T J | |
| 700 | 1 | _aChang, J C | |
| 700 | 1 | _aLiu, M W | |
| 700 | 1 | _aTai, T Y | |
| 700 | 1 | _aHsu, W H | |
| 700 | 1 | _aChuang, L M | |
| 773 | 0 |
_tDiabetes _gvol. 50 _gno. 11 _gp. 2598-602 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diabetes.50.11.2598 _zAvailable from publisher's website |
| 999 |
_c11596447 _d11596447 |
||